Published • loading... • Updated
Parent Project Muscular Dystrophy, Foundation to Eradicate Duchenne Announce 2026 Advocacy Leadership Awards Recipients Honoring Bipartisan Champions in Congress
Awards honor bipartisan congressional leaders for advancing Duchenne and Becker muscular dystrophy research and care, marking 25 years of progress since the MD-CARE Act.
- On March 9, 2026, Parent Project Muscular Dystrophy and the Foundation to Eradicate Duchenne announced five bipartisan Congress members as 2026 Advocacy Leadership Award recipients. The awards honor leaders who advanced policies on Duchenne and Becker muscular dystrophy.
- Marking the law's 25th anniversary, organizers highlighted the MD-CARE Act, enacted in 2001 to create a federal framework for muscular dystrophy research and care.
- The awards recognize bipartisan leaders for advancing federal policies that accelerate Duchenne and Becker research, strengthen care infrastructure, and expand access to therapies.
- Presented during PPMD's 2026 Advocacy Conference, Lauren Stanford and Joel Wood said the honorees exemplify how advocacy and policy produce meaningful outcomes, reflecting sustained efforts.
- The Foundation to Eradicate Duchenne — founded by Dana and Joel Wood in 2000 — and PPMD, founded in 1994, remain focused on advancing policies that improve the lives of those with Duchenne and Becker.
Insights by Ground AI
28 Articles
28 Articles
Coverage Details
Total News Sources28
Leaning Left3Leaning Right4Center8Last UpdatedBias Distribution53% Center
Bias Distribution
- 53% of the sources are Center
53% Center
L 20%
C 53%
R 27%
Factuality
To view factuality data please Upgrade to Premium















